Non‐clinical single‐ and repeated‐dose toxicity studies of ET‐26 hydrochloride in rats
- 13 March 2020
- journal article
- research article
- Published by Wiley in Journal of Applied Toxicology
- Vol. 40 (8) , 1099-1112
Abstract
ET‐26 hydrochloride (ET‐26HCl), a novel analog of etomidate, induces as effective sedation, with good cardiac and respiratory stability, as etomidate but with mild adrenocortical suppression. The objective of this study was to evaluate the potential adverse effects of ET‐26HCl in rats. In a single‐dose toxicity study, abnormal urine color (red) was observed in all groups: control (100%), 8 mg/kg (10%), 16 mg/kg (50%), and 20 mg/kg (70%) ET‐26HCl, which returned to normal on the day of dosing. There were no mortalities or serious toxicological signs; the maximum tolerable dose of ET‐26HCl was 20 mg/kg. In the repeated‐dose toxicity study, deaths occurred in the 12‐ (13.33% of males) and 16‐mg/kg/day (20% of males and 3.33% of females) groups. Abnormal urine color (red or brown) was detected in the control group (10%) and all treatment groups (30%, 46.67%, and 40% at 8, 12 and 16 mg/kg/day, respectively), at a frequency of 1.43% in the control group, 4.76% in 8 mg/kg/day, 7.62% in 12 mg/kg/day, and 4.29% in 16 mg/kg/day. Increases in neutrophils and plasma fibrinogen were temporary and recoverable effects. Macroscopic and histopathologic changes were found only at the injection sites: abnormal skin color, scabbing, thrombus, ulceration, and inflammation. During the recovery period, there was evidence of reversibility, including fibroblast proliferation and vessel recanalization. The no‐observed‐adverse‐effect level of ET‐26HCl was 8 mg/kg/day. Toxicokinetic variables of ET‐26HCl, except the calculated initial concentration in females on Day 1, showed a dose‐dependent increase to exposure, with no gender difference and no evidence of accumulation.Keywords
Funding Information
- Ministry of Science and Technology of the People's Republic of China (2014ZX09101001)
- National Natural Science Foundation of China (81973274)
This publication has 13 references indexed in Scilit:
- Pharmacologic studies on ET-26 hydrochloride in a rat model of lipopolysaccharide-induced sepsisEuropean Journal of Pharmaceutical Sciences, 2017
- Searchable attribute-based encryption scheme with attribute revocation in cloud storagePLOS ONE, 2017
- An Etomidate Analogue With Less Adrenocortical Suppression, Stable Hemodynamics, and Improved Behavioral Recovery in RatsAnesthesia & Analgesia, 2017
- Metabolite-inactive etomidate analogues alleviating suppression on adrenal function in Beagle dogsEuropean Journal of Pharmaceutical Sciences, 2017
- Hematoxylin and Eosin Staining of Tissue and Cell SectionsCold Spring Harbor Protocols, 2008
- Exploratory assessment of dose proportionality: review of current approaches and proposal for a practical criterionPharmaceutical Statistics, 2008
- Solvent for etomidate may cause pain and adverse effectsBritish Journal of Anaesthesia, 1999
- Haemolysis after etomidate: comparison of propylene glycol and lipid formulationsBritish Journal of Anaesthesia, 1997
- Toxicology, metabolism, and biochemistry of 1,2-propanediolToxicology and Applied Pharmacology, 1972
- Hematologic effects following the intravenous injection of propylene glycol in the rabbitToxicology and Applied Pharmacology, 1962